Caraco Pharmaceuticals withheld information about FDA recalls and other problems, and its share price plunged from $10.17 to $2.39 when the truth came out, shareholders say in Detroit Federal Court.
Bare Escentuals inflated its share price through false and misleading statements, shareholders say in San Francisco Federal Court.
Shareholders say MSC Software is selling itself too cheaply to Maximus Holdings, for $7.63 a share, or $360 million in Orange County Court, Calif.
Kenexa Corp. inflated its share price by withholding information about its financial condition, shareholders say in Philadelphia Federal Court.
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
Additional Reads
-
EU gains trillions in revenue — and debt April 22, 2024 -
Alaska, Hawaiian Airlines April 17, 2024
-
-
Contributor-Test-Post-2024-04-12 April 12, 2024